Your browser doesn't support javascript.
loading
Show: 20 | 50 | 100
Results 1 - 2 de 2
Filter
Add filters








Year range
1.
Acta Pharmaceutica Sinica ; (12): 1057-1063, 2010.
Article in Chinese | WPRIM | ID: wpr-353384

ABSTRACT

The aim of this study is to investigate the critical factor affecting the properties of PLGA microspheres fabricated by a solid-in-oil-in-water (S/O/W) emulsion technique with BSA as a model protein. Prior to encapsulation, the BSA microparticles were fabricated by a modified freezing-induced phase separation method. The microparticles were subsequently encapsulated into PLGA microspheres by S/O/W emulsion method, then Motic BA200 biological microscope, confocal laser scanning microscope, scanning electron microscope were used to observe the structure of S/O/W emulsion and PLGA microspheres. The protein content extracted or released from BSA microspheres was measured by Bradford protein assay method. It was found that NaCl added in the outer aqueous phase effectively suppressed material exchange between the inner and outer phase of S/O/W emulsion. Then, the structure and permeability of obtained microspheres were influenced. As a result, with the increase of NaCl concentration in the outer aqueous phase, the encapsulation efficiency of microspheres significantly increased from 60% to more than 85%, the burst release of microspheres reduced from 70% to 20%, and the particle size decreased from 103 microm to 62 microm. Furthermore, the rehydration of encapsulated protein was also retarded and then integrity of BSA was successfully protected during encapsulation process. In vitro release test showed that BSA released from PLGA microspheres in a sustained manner for more than 30 days.


Subject(s)
Delayed-Action Preparations , Drug Compounding , Emulsions , Chemistry , Lactic Acid , Chemistry , Microscopy, Confocal , Microscopy, Electron, Scanning , Microspheres , Oils , Particle Size , Polyglycolic Acid , Chemistry , Serum Albumin, Bovine , Chemistry , Sodium Chloride , Chemistry , Water
2.
Acta Pharmaceutica Sinica ; (12): 12-18, 2006.
Article in English | WPRIM | ID: wpr-271492

ABSTRACT

<p><b>AIM</b>To produce poly (lactic-co-glycolic acid) (PLGA) microspheres, containing a staphylokinase variant (K35R, DGR) with reduced immunogenecity and antiplatelet aggregation activities, which allowed the preservation of protein stability during both particle processing and drug release.</p><p><b>METHODS</b>DGR-loaded microspheres were fabricated using a double emulsion-solvent evaporation technique. The effects of preparative parameters, such as stirring rate, polymer concentration, and the excipients of both internal and external aqueous phase (W2), on DGR encapsulation efficiency and microsphere characteristics were investigated. In vitro and in vivo release of DGR were conducted and the cause for instability of DGR during release was also investigated.</p><p><b>RESULTS</b>Moderate ultrasonic treatment of aqueous DGR/dichloromethane mixtures caused approximately. Eighty four per cent DGR denaturation. However, the activity recovery of DGR almost amounted to 100% when 2% polyvinyl alcohol (PVA) was addled into the aqueous phase. It was found that NaCl in the external water phase significantly increased DGR encapsulation efficiency. Furthermore, NaCl in the external water phase played a role in determining size and surface morphology of microsphere. In vitro release test showed a burst release of DGR from microspheres, followed by sustained release of 50% total activity over 15 days. In vivo experiments showed that DGR released from microspheres sustained 5 days. Denaturation of DGR within microspheres might be resulted from acidic microclimate.</p><p><b>CONCLUSION</b>The stability of DGR was effectively protected during microencapsulation and a relatively high encapsulation efficiency of DGR was obtained. PLGA microspheres could be an effective carrier for DGR.</p>


Subject(s)
Animals , Male , Rabbits , Area Under Curve , Drug Carriers , Drug Compounding , Drug Delivery Systems , Escherichia coli Proteins , Genetics , Pharmacokinetics , Genetic Variation , Lactic Acid , Metalloendopeptidases , Genetics , Pharmacokinetics , Microspheres , Particle Size , Polyglycolic Acid , Polymers
SELECTION OF CITATIONS
SEARCH DETAIL